Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 20/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13648719 | 0.92 | CSNK2A1 (0.65) | CSNK2A1 | |
| SCHEMBL13648707 | 0.92 | CSNK2A1 (0.77) | CSNK2A1 | |
| SCHEMBL13687966 | 0.90 | CSNK2A1 (0.75) | CSNK2A1 | |
| SCHEMBL13648708 | 0.89 | CSNK2A1 (0.60) | CSNK2A1 | |
| SCHEMBL13648710 | 0.88 | CSNK2A1 (0.59) | CSNK2A1 | |
| SCHEMBL10132689 | 0.87 | CSNK2A1 (1.00) | CSNK2A1 | |
| SCHEMBL13649099 | 0.87 | CSNK2A1 (0.69) | CSNK2A1 | |
| SCHEMBL13648714 | 0.86 | CSNK2A1 (0.77) | CSNK2A1 | |
| SCHEMBL13648716 | 0.86 | CSNK2A1 (0.58) | CSNK2A1 | |
| SCHEMBL13648712 | 0.85 | CSNK2A1 (0.62) | CSNK2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090264423-A2 | SERINE-THREONINE PROTEIN KINASE AND PARP MODULATORS | CYLENE PHARMACEUTICALS, INC. (US) | 2009-10-22 | — | — | US | disclosed |
| US-20090264423-A2 | SERINE-THREONINE PROTEIN KINASE AND PARP MODULATORS | CYLENE PHARMACEUTICALS, INC. (US) | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264423-A2 | SERINE-THREONINE PROTEIN KINASE AND PARP MODULATORS | PACSIN2, TNKS, PARP1 | CSNK2A1 24/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.